Analysis and commentary from clinicians, researchers and patients across the field.
In the eight years since, the NHS has issued just five prescriptions for unlicenced specials cannabis medicines, creating a two-tier system with access only to those who can afford to pay for it.
In this bi-weekly series, Dr Sue Clenton explores the growing interest and potential of cannabinoid-based therapies to address unmet needs in women’s health conditions.
Since launching its legal support helpline, Releaf Cannabis Clinic has received increasing reports from patients experiencing stigma and discrimination.
Medical cannabis patients are often framed as consumers chasing the next strain, but that overlooks how many navigate treatment, writes Dave Barton.
Medical cannabis has been legal in the UK since 2018, but for many patients, taking or carrying their prescribed medication in public still comes with uncertainty. Since launching its legal […]
Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine.
Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine.
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging […]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging […]
How one oncologist is helping redefine patient care and the future of integrated healthcare. Medical cannabis is starting to have a very different kind of conversation in the UK. From […]
James Smith, co-founder of 4C Labs, shares his recent experience using cannabis-based medicines after a hip replacement.
Words by Dr Sue Clenton, Medical Director, Releaf If we are serious about the future of medical cannabis in the UK, we must be equally serious about its clinical […]
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
See all events4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall
